Skip to main content


From Biogenic Amines to New Mechanisms of Action

  • Book
  • © 2019


  • Outlines the most up to date evidence regarding the treatment of depression
  • Concise, yet comprehensive, in its review of clinical evidence
  • Appeals to both clinicians and researchers alike

Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 250)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

About this book

This volume reviews the known neurobiology of depression and combines classic data on antidepressant treatments with modern theory on the physiology of depression. It also discusses novel mechanism of action drugs.

Similar content being viewed by others


Table of contents (17 chapters)

Editors and Affiliations

  • School of Medicine-Wichita, University of Kansas, Wichita, USA

    Matthew Macaluso, Sheldon H. Preskorn

Bibliographic Information

Publish with us